Navigation Links
Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application
Date:7/11/2014

SARASOTA, Fla., July 11, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI), an emerging biotechnology company, today announced that the Food and Drug Administration ("FDA"), has notified the Company that the agency will provide comments on RCP's Investigational New Drug ("IND") application before granting the Company permission to start its clinical trial in the US.

Dr. Chris Chapman, RCP's President, commented, "We appreciate the agency's review and comments on our IND. When we receive the agency's official comments and/or recommendations, we will respond expeditiously. We look forward to moving this important product through the regulatory process."

Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical dietary supplements products, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and
'/>"/>

SOURCE Rock Creek Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AMG Medical Inc. Selects Saddle Creek for Multichannel Fulfillment
2. A Forever Recovery Battle Creek, MI: Increasing Recreational Drug Use in Colleges Creates Risk for Addictions
3. Creekridge Capital Continues Vendor Growth within Technology
4. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
5. Creekridge Capital Announces Record Volume
6. Creekridge Capital Adds Revolving Credit Specialist
7. Creekridge Capital Expands Healthcare Sales Team
8. Creekridge Capital Launches Vendor Sales Training Program
9. Creekridge Capital Grows Healthcare Sales Team
10. Creekridge Breaks Monthly and Quarterly Volume Records
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 /PRNewswire/ ... acquisition of assets related to the ion channel biology ... had previously been obtained as part of Pfizer,s 2011 ... of Pfizer,s rights to the "Icagen" name and trademark. ... provide comprehensive services for ion channel and transporter drug ...
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... the leading Health Image Intelligence™ company, announces that it will ... International Definiens Symposium at the Moffitt Cancer Center ... the premier forum for Definiens users and developers from around ... in life science image and data analysis. One focus of ...
... www.theravasc.com ) announced the successful completion of a Phase I ... trial included 12 diabetic patients who each received a single ... coated and a non-enteric coated capsule, to determine safety and ... in animals, the circulating blood levels in all patients were ...
Cached Medicine Technology:Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium 2Definiens to Introduce New Generation of Products for Tissue-based Biomarker Research at the International Definiens Symposium 3TheraVasc Releases Phase I Trial Data Demonstrating Safety of Drug in Diabetic Patients 2
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer ... sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and ... highly respected and well established national certification organization for renewable energy professionals. Designation ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... sessions and speaker lineup for its 2015 Annual Conference , the ... 6-8, 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national chief nursing ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
(Date:7/3/2015)... ... , ... Jennifer Renee Hanes, DO is the new Medical Director of its ... independent freestanding emergency rooms in the United States. , “We are excited to welcome ... Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. , ...
(Date:7/3/2015)... ... July 03, 2015 , ... Every year, One-to-1 Fitness and ... they provide members of the Red Deer community with free fitness training and indoor ... training, games, food, events and entertainment raised thousands of charity dollars and ended with ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
... Available Digitally on iTunes June 10th and In-Stores July 1st ... runaway hit overseas, Chant,- Music For The Soul debuted at ... bested the likes of Amy Winehouse and Leona Lewis. Not,surprising ... is a,much-needed growing phenomenon, featuring traditional chant from the 12th,and ...
... DIEGO and MCLEAN, Va., June 10 SAIC, Inc.,(NYSE: ... Blair Annual,Growth Stock Conference in Chicago on June 18, 2008. ... 3:10 p.m. Central., A live audio webcast of the ... ( http://investors.saic.com ) and an audio,replay of the event will ...
... PITTSBURGH, June 10 Mylan Inc. (NYSE: MYL ... the Federal Circuit has,affirmed a May 2007 District Court ... delayed-release capsules do not infringe patents asserted,against Mylan by ... Mylan launched its Omeprazole products on August 4, ...
... perform, yields instant result, study says , , TUESDAY, June ... have a longer than normal QRS duration (a measurement ... an electrocardiogram) appear to have a high risk of ... data from 2,962 patients hospitalized for heart failure who ...
... popularity of golf carts has skyrocketed in recent years, ... injuries. In fact, a new study conducted by researchers ... The Research Institute at Nationwide Children,s Hospital found that ... during the 17-year study period. , According to ...
... Selective,Insurance Group, Inc. (Nasdaq: SIGI ) announced ... of America ("Selective"):, Fred J. Ferraro (New ... manager. Previously he served as vice president and ... 2003 as a senior,equity research analyst. Prior to ...
Cached Medicine News:Health News:Live a Longer and More Peaceful Life With Chant - Music For The Soul 2Health News:SAIC to Webcast Presentation at William Blair Growth Stock Conference 2Health News:ECG Reading May Predict Death, Rehospitalization Risk 2Health News:First national study to examine golf cart-related injuries 2Health News:Selective Insurance Group Announces Officer Appointments 2Health News:Selective Insurance Group Announces Officer Appointments 3